Portfolio (Quarterly)
Guide ↗
Viking Global Investors
· CIK 0001103804| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 61 | — | NEWAMSTERDAM PHARMA COMPANY | — | 4,203,567.0 | $147.5M | 0.39% | NEW | — | $35.08 | — |
| 62 | ROIV | ROIVANT SCIENCES LTD | Healthcare | 6,443,191.0 | $139.8M | 0.37% | NEW | — | $21.70 | +61.6% |
| 63 | — | IQVIA HLDGS INC | — | 619,236.0 | $139.6M | 0.37% | NEW | — | $225.41 | — |
| 64 | SION | SIONNA THERAPEUTICS INC | Healthcare | 3,195,181.0 | $131.4M | 0.35% | NEW | — | $41.14 | +5.1% |
| 65 | — | INHIBRX BIOSCIENCES INC | — | 1,437,705.0 | $113.6M | 0.30% | NEW | — | $79.00 | — |
| 66 | PHVS | PHARVARIS N V | Healthcare | 3,653,310.0 | $101.4M | 0.27% | NEW | — | $27.75 | +24.4% |
| 67 | CSGP | COSTAR GROUP INC | Real Estate | 1,442,582.0 | $97.0M | 0.26% | NEW | — | $67.24 | -57.3% |
| 68 | WST | WEST PHARMACEUTICAL SVSC INC | Healthcare | 295,028.0 | $81.2M | 0.21% | NEW | — | $275.14 | +28.2% |
| 69 | ORKA | ORUKA THERAPEUTICS INC | Healthcare | 2,666,690.0 | $80.8M | 0.21% | NEW | — | $30.31 | +202.8% |
| 70 | LAB | STANDARD BIOTOOLS INC | Healthcare | 58,651,170.0 | $75.1M | 0.20% | NEW | — | $1.28 | -41.0% |
| 71 | MASI | MASIMO CORP | Healthcare | 514,340.0 | $66.9M | 0.18% | NEW | — | $130.06 | +38.4% |
| 72 | ORIC | ORIC PHARMACEUTICALS INC | Healthcare | 6,572,691.0 | $53.8M | 0.14% | NEW | — | $8.18 | +25.2% |
| 73 | TRVI | TREVI THERAPEUTICS INC | Healthcare | 3,198,644.0 | $40.0M | 0.11% | NEW | — | $12.52 | +51.1% |
| 74 | DNA | GINKGO BIOWORKS HOLDINGS INC | Healthcare | 3,577,128.0 | $29.7M | 0.08% | NEW | — | $8.31 | +23.7% |
| 75 | PEPG | PEPGEN INC | Healthcare | 3,482,434.0 | $22.7M | 0.06% | NEW | — | $6.51 | -72.7% |
| 76 | — | RALLYBIO CORP | — | 4,194,777.0 | $2.9M | 0.01% | NEW | — | $0.69 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Financial Services
24.1%
Consumer Cyclical
19.9%
Technology
15.2%
Healthcare
12.5%
Industrials
10.7%
Communication Services
7.8%
Basic Materials
6.0%
Real Estate
3.8%